What are analysts Suggestions on Proteostasis Therapeutics, Inc.(NASDAQ:PTI): Centrais Electricas Brasileiras S.A.- Eletrobras(NYSE:EBR)

0
5

Proteostasis Therapeutics, Inc. (PTI) will report its next earnings on Mar 06 AMC. The company reported the earnings of $-0.25/Share in the last quarter where the estimated EPS by analysts was $-0.4/share. The difference between the expected and actual EPS was $0.15/share, which represents an Earnings surprise of 37.5%.

Many analysts are providing their Estimated Earnings analysis for Proteostasis Therapeutics, Inc. and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $-0.29/share. These analysts have also projected a Low Estimate of $-0.33/share and a High Estimate of $-0.25/share.

These analysts also forecasted Growth Estimates for the Current Quarter for PTI to be 19.4%. They are projecting Next Quarter growth of -25%. For the next 5 years, Proteostasis Therapeutics, Inc. is expecting Growth of -6.94% per annum, whereas in the past 5 years the growth was 25.47% per annum.

Some buy side analysts are also providing their Analysis on Proteostasis Therapeutics, Inc., where 3 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.07 and Average Volume (3 months) is 5.87 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -55.9%. The Return on Equity (ROE) value stands at -69.9%. While it’s Return on Investment (ROI) value is -55.3%.

While looking at the Stock’s Performance, Proteostasis Therapeutics, Inc. currently shows a Weekly Performance of -4.62%, where Monthly Performance is -14.95%, Quarterly performance is 54.21%, 6 Months performance is 142.43% and yearly performance percentage is -58.02%. Year to Date performance value (YTD perf) value is -27.63%. The Stock currently has a Weekly Volatility of 6.03% and Monthly Volatility of 7.17%.

Many analysts are providing their Estimated Earnings analysis for Centrais Electricas Brasileiras S.A.- Eletrobras and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

Some buy side analysts are also providing their Analysis on Centrais Electricas Brasileiras S.A.- Eletrobras, where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.84 and Average Volume (3 months) is 409.6 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of 0%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Centrais Electricas Brasileiras S.A.- Eletrobras currently shows a Weekly Performance of -4.83%, where Monthly Performance is -15.5%, Quarterly performance is -9.11%, 6 Months performance is -20.15% and yearly performance percentage is -17.29%. Year to Date performance value (YTD perf) value is -13.41%. The Stock currently has a Weekly Volatility of 2.83% and Monthly Volatility of 2.91%.

SHARE